Table 3 Predictive factors on the change of BCVA
From: Modified endoscopic transnasal orbital apex decompression in dysthyroid optic neuropathy
Univariate model | Multivariate model | |||
|---|---|---|---|---|
Estimate (95% CI) | P value | Estimate (95% CI) | P value | |
Baseline age, per year older | −0.01 (−0.03, 0.00) | 0.139 | – | – |
Gender: Male | 0.17 (−0.14, 0.46) | 0.294 | – | – |
Smoking history: never | 0.17 (−0.51, 0.84) | 0.632 | – | – |
TSH level, per 1 uIU/ml higher | −0.02 (−0.04, 0.00) | 0.083 | – | – |
BMI, per 1 higher | −0.01 (−0.07, 0.05) | 0.719 | ||
IVGC therapy: never | −0.11 (−0.45, 0.23) | 0.524 | – | – |
Duration of DON, per month longer | 0.00 (0.00, 0.00) | 0.944 | – | – |
Preop. CAS, per 1 score higher | −0.05 (−0.18, 0.06) | 0.928 | – | – |
Medium rectus diameter, per 1 mm thicker | 0.08 (0.02, 0.13) | 0.008** | 0.07 (0.01, 0.13) | 0.019* |
Preop. BCVA, per 0.1 LogMAR higher | 0.08 (0.07, 0.09) | < 0.001*** | 0.08 (0.07, 0.09) | < 0.001*** |
Preop. MD, per 1 dB greater | −0.03 (−0.04, −0.01) | < 0.001*** | −0.04 (−0.05, −0.02) | < 0.001*** |
Preop. exophthalmos, per 1 mm higher | 0.04(0.00, 0.09) | 0.051 | – | – |